Olga Uspenskaya-Cadoz

Company: Eli Lilly & Co.

Job title: Vice President, Clinical Development

Seminars:

Panel Discussion: Given Recent Failures, How Can we Tailor ALS Clinical Trials to Successfully Meet Regulatory Expectations 1:30 pm

Outlining the approval path for sporadic and familial ALS: is it the same for different modalities? What is the regulatory bar for approving this? Harnessing innovative trial design Cross comparing diverging requirements for different regulatory agencies including the FDA, EMA and more Establishing clear, patient-relevant endpoints and leveraging biomarkers to demonstrate efficacy Critically identifying stumbling…Read more

day: Conference Day One Track B PM